Skip to search formSkip to main contentSkip to account menu

negative regulation of TRAIL receptor 2 biosynthetic process

Known as: negative regulation of TRAIL receptor 2 synthesis, negative regulation of TRAIL receptor 2 anabolism, downregulation of TRAIL receptor 2 biosynthetic process 
Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of TRAIL… 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

biological control

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Effects of a trail mountain race on neuromuscular performance and hydration status in trained runners.
BACKGROUND The aims of this study were to examine the effects of a trail mountain race (TMR) on hydration status and… 
2018
2018
A‐1210477 sensitizes TRAIL-induced apoptosis in MDA-MB-231 Triple Negative Breast Cancer cells.
2015
2015
Role Of S-Nitrosylation In The Extrinsic Apoptotic Signalling Pathway In Cancer.
2011
2011
Glucocorticoid receptor antagonist sensitizes TRAIL-induced apoptosis in renal carcinoma cells through up-regulation of DR5 and down-regulation of c-FLIP(L) and Bcl-2
RU486 (Mifepristone) has been known as antiprogesterone and antiglucocorticoid agent. RU486 is also used for treatment of several… 
2010
2010
Biomarkers for predicting the sensitivity of cancer cells to TRAIL-R1 agonistic monoclonal antibody.
Review
2009
Review
2009
Apo 2 L / TRAIL Inhibits Tumor Growth and Bone Destruction in aMurineModel of Multiple Myeloma
Purpose:Multiple myeloma is an incurable disease, for which the development of new therapeutic approaches is required. Here, we… 
2007
2007
INVESTIGATING THE INTERACTION BETWEEN OSTEOPROTEGERIN AND RANKL OR TRAIL: EVIDENCE FOR A PIVOTAL ROLE FOR OSTEOPROTEGERIN IN REGULATING TWO DISTINCT PATHWAYS
was 23 nM. These data suggest that OPG can bind both RANKL and TRAIL and that the affinity of OPG for these two ligands is of a… 
2005
2005
HGS-ETR1, a fully human monoclonal antibody to the tumor necrosis factor-related apoptosis-inducing ligand death receptor 1 (TRAIL-R1) in patients with advanced solid cancer: Results of a phase 1…
3052 Introduction: HGS-ETR1 (TRM-1) is a fully human monoclonal antibody that is agonistic to the R1 (TRAIL-R1 or DR4) receptors… 
2004
2004
208 HGS-ETR1, a fully human monoclonal antibody to the tumor necrosis factor-related apoptosis-inducing ligand death receptor 1 (TRAIL-R1) in patients with advanced solid cancer: results of a phase I…
1998
1998
Receptor que fija trail.
Un polipeptido receptor de ligando que induce la apoptosis relacionada con el TNF (TRAIL-R) purificado, que se une al ligando que… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)